Serum concentrations of carboxyterminal propeptide of type 1 procollagen and tissue inhibitor of metalloproteinase 1 in patients with dermatomyositis

Archives of Dermatological Research

Volumn 290, Issue 5, 1998, Pages 253-257

  Kubo, Masahide ^a   Kikuchi, Kanako ^a   Fujimoto, Manabu ^a   Tamaki, Kunihiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Dermatomyositis; Procollagen; TIMP 1

Indexed keywords

COLLAGENASE; CREATINE KINASE; PROCOLLAGEN; TISSUE INHIBITOR OF METALLOPROTEINASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DERMATOMYOSITIS; DISEASE ACTIVITY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROSIS; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CREATINE KINASE; DERMATOMYOSITIS; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PROCOLLAGEN; SEX FACTORS; TIME FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 0031864289     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004030050300     Document Type: Article

References (24)

1. Yamazaki M, Minota S, Sakurai H, Miyazono K, Yamada A, Kanazawa I, Kawai M (1994) Expression of transforming growth factor-beta 1 and its relation to endomysial fibrosis in progressive muscular dystrophy. Am J Pathol 144:221-226
2. Rohde H, Vargas L, Hahn E, Kalbfleisch H, Bruguera M, Timpl R (1979) Radioimmunoassay for type III procollagen peptide and its application to human liver disease. Eur J Clin Invest 9:451-459
3. Frei A, Zimmermann A, Weigand K (1984) The N-terminal propeptide of collagen type III in serum reflects activity and degree of fibrosis in patients with chronic liver disease. Hepatology 4:830-834
4. Risteli L, Risteli J (1990) Non-invasive methods for detection of organ fibrosis. In: Rojkind M (ed) Focus on connective tissue in health and disease. vol 1. CRC Press, Boca Raton, pp 61-98
5. Kroger H, Risteli J, Risteli L, Penttila I, Alhava E (1993) Serum osteocalcin and carboxyterminal propeptide of type I procollagen in rheumatoid arthritis. Ann Rheum Dis 52:338-342
6. Cortet B, Flipo RM, Pigny P, Duquesnoy B, Racadot A, Boersma A, Delcambre B (1997) How useful are bone turnover markers in rheumatoid arthritis? Influence of disease activity and corticosteroid therapy. Rev Rhum Engl Ed 64:153-159
7. Krieg T, Langer I, Gerstmeier H, Keller J, Mensing H, Goerz G, Timpl R (1986) Type III collagen aminopropeptide levels in serum of patients with progressive systemic scleroderma. J Invest Dermatol 87:788-791
8. Majewski S, Skiendzielewska A, Makiela B, Jablonska S, Blaszczyk M (1987) Serum levels of type III collagen aminopropeptide in patients with systemic scleroderma. Arch Dermatol Res 279:484-486
9. Black CM, McWhirter A, Harrison NK, Kirk JM, Laurent GJ (1989) Serum type III procollagen peptide concentrations in systemic sclerosis and Raynaud's phenomenon: relationship to disease activity and duration. Br J Rheumatol 28:98-103
10. Quinones F, Crouch E (1986) Biosynthesis of interstitial and basement membrane collagens in pulmonary fibrosis. Am Rev Respir Dis 134:1163-1171
11. McDonald JA, Broekelmann TJ, Matheke ML, Crouch E, Koo M, Kuhn C III (1986) A monoclonal antibody to the carboxy-terminal domain of procollagen type I visualizes collagen-synthesizing fibroblasts. Detection of an altered fibroblast phenotype in lungs of patients with pulmonary fibrosis. J Clin Invest 78:1237-1244
12. Kikuchi K, Ihn H, Sato S, Igarashi A, Soma Y, Ishibashi Y, Takehara K (1994) Serum concentration of procollagen type I carboxyterminal propeptide in systemic sclerosis. Arch Dermatol Res 286:77-80
13. Koch S, Tillmann B (1995) The distal tendon of the biceps brachii. Structure and clinical correlations. Anat Anz 177:467-474
14. Cawston TE (1986) Protein inhibitors of metallo-proteinases. In: Barrett AJ, Salveson G (eds) Proteinase inhibitors. Elsevier, Amsterdam, pp 589-610
15. Murawaki Y, Yamamoto H, Kawasaki H, Shima H (1993) Serum tissue inhibitor of metalloproteinases in patients with chronic liver disease and with hepatocellular carcinoma. Clin Chim Acta 218:47-58
16. Li J, Rosman AS, Leo MA, Nagai Y, Lieber CS (1994) Tissue inhibitor of metalloproteinase is increased in the serum of pre-cirrhotic and cirrhotic alcoholic patients and can serve as a marker of fibrosis. Hepatology 19:1418-1423
17. Kikuchi K, Kubo M, Sato S, Fujimoto M, Tamaki K (1995) Serum tissue inhibitor of metalloproteinases in patients with systemic sclerosis. J Am Acad Dermatol 33:973-978
18. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis. N Engl J Med 292:344-347
19. Kanayama N, Terao T (1992) Relationship of serum levels of pro-type I collagen peptide, pro-type III collagen peptide and type IV 7S collagen with cervical maturation. Gynecol Obstet Invest 34:24-26
20. Kodama S, Iwata K, Iwata H, Yamashita K, Hayakawa T (1990) Rapid one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases. An application for rheumatoid arthritis serum and plasma. J Immunol Methods 127:103-108
21. Fessier JH, Fessier LI (1978) Biosynthesis of procollagen. Annu Rev Biochem 47:129-162
22. Hupli M, Hum H, Luoto S, Risteli L, Vanharanta H, Risteli J (1997) Low synthesis rate of type I procollagen is normalized during active back rehabilitation. Spine 22:850-854
23. Slavin J, Unemori E, Hunt TK, Amento E (1994) Transforming growth factor beta (TGF-beta) and dexamethasone have direct opposing effects on collagen metabolism in low passage human dermal fibroblasts in vitro. Growth Factors 11:205-213
24. Aubert JD, Dalal BI, Bai TR, Roberts CR, Hayashi S, Hogg JC (1994) Transforming growth factor beta 1 gene expression in human airways. Thorax 49:225-232